GRANULATORS FOR PHARMACEUTICAL MARKET ANALYSIS

Pharmaceutical Granulators Market– Insights

Increasing demand for oral dose medications in the pharmaceutical industry is expected to drive growth of pharmaceutical granulators market. The granulators are used in the process of granulation in which enlargement of particles by agglomeration technique is done. It is one of the most significant operations in the production of pharmaceutical oral solid dosage forms (mostly tablets and capsules). Oral medications have higher preference owing to advantages such as safety of patient, patient compliance, adherence in terms of ease of ingestion, pain avoidance, and versatility in accommodating various types of drugs.

For instance, according to the Nice Insight Pharmaceutical Excipient Survey report of 2017, 65% of the pharmaceutical excipients manufactured are in oral solid dosage. Most pharmaceutical granulators are used for granulation and manufacturing of solid dosage forms. Dry and wet granulation methods are majorly used for tablet and capsules manufacturing. Compaction is also used to densify the powder and form granules.

The global pharmaceutical granulators market is estimated to be valued at US$ 3,435.8 million in 2019, and is expected to exhibit a CAGR of 5.6% over the forecast period (2020-2027).

Global Pharmaceutical Granulators Market Share (%) Analysis, By Product Type, 2019

To learn more about this report, Request sample copy

Source: Coherent Market Insights Analysis (2020)

Global Pharmaceutical Granulators Market- Regional Insights

On the basis of region, the global pharmaceutical granulators market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region for growth of the pharmaceutical granulators market owing to presence of pharmaceutical manufacturers in the region with huge production plants that involve mass manufacturing and development of oral pharmaceutical drugs.

Moreover, expansion of production facilities by existing pharmaceutical players and introduction of new production plants by players in the pharmaceutical industry are also contributing to growth of the market in North America. For instance, in March 2017, Apotex, Inc., a Canadian pharmaceutical company, announced an investment of US$ 184 million for expansion of its advanced manufacturing and R&D facility in Florida. Additionally, according to a survey report published by the USFDA in 2016, the top 15 pharmaceutical companies in the U.S. invested an estimated 20.5% of their pharmaceutical sales in research and development of new drugs.

Asia Pacific pharmaceutical granulators market revenue is expected to witness significant growth due to increasing investments by leading pharmaceutical players in expansion of their production units in the region. For instance, in March 2018, Merck KGaA invested US$ 47 million for expansion of manufacturing plants in South Korea and India to develop biologics and other pharmaceutical drugs.

Global Pharmaceutical Granulators Market, Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

To learn more about this report, Request sample copy

Source: Coherent Market Insights Analysis (2020)

Global Pharmaceutical Granulators Market- Competitive Landscape

Major players operating in the global pharmaceutical granulators market include L.B. Bohle, Alexanderwerk, GEA Group Aktiengesellschaft, Frewitt S.A., LINXIS Group, Spraying Systems Co., Syntegon Technology GmbH, Romaco Group, Gebrüder Lödige Maschinenbau GmbH, and Glatt GmbH.